Despite the thousands of genes implicated in age-related phenotypes, effective interventions for aging remain elusive, a lack of advance rooted in the multifactorial nature of longevity and the functional interconnectedness of the molecular components implicated in aging. Here, we introduce a network medicine framework that integrates 2,358 longevity-associated genes onto the human interactome to identify existing drugs that can modulate aging processes. We find that genes associated with each hallmark of aging form a connected subgraph, or hallmark module, a discovery enabling us to measure the proximity of 6,442 clinically approved or experimental compounds to each hallmark. We then introduce a transcription-based metric, $pAGE$, which evaluates whether the drug-induced expression shifts reinforce or counteract known age-related expression changes. By integrating network proximity and $pAGE$, we identify multiple drug repurposing candidate that not only target specific hallmarks but act to reverse their aging-associated transcriptional changes. Our findings are interpretable, revealing for each drug the molecular mechanisms through which it modulates the hallmark, offering an exp
Simulating prospective magnetic resonance imaging (MRI) scans from a given individual brain image is challenging, as it requires accounting for canonical changes in aging and/or disease progression while also considering the individual brain's current status and unique characteristics. While current deep generative models can produce high-resolution anatomically accurate templates for population-wide studies, their ability to predict future aging trajectories for individuals remains limited, particularly in capturing subject-specific neuroanatomical variations over time. In this study, we introduce Individualized Brain Synthesis (InBrainSyn), a framework for synthesizing high-resolution subject-specific longitudinal MRI scans that simulate neurodegeneration in both Alzheimer's disease (AD) and normal aging. InBrainSyn uses a parallel transport algorithm to adapt the population-level aging trajectories learned by a generative deep template network, enabling individualized aging synthesis. As InBrainSyn uses diffeomorphic transformations to simulate aging, the synthesized images are topologically consistent with the original anatomy by design. We evaluated InBrainSyn both quantitativ
We investigate the effects of aging in the noisy voter model considering that the probability to change states decays algebraically with age $τ$, defined as the time elapsed since adopting the current state. We study the complete aging scenario, which incorporates aging to both mechanisms of interaction: herding and idiosyncratic behavior, and compare it with the partial aging case, where aging affects only the herding mechanism. Analytical mean-field equations are derived, finding excellent agreement with agent-based simulations on a complete graph. We observe that complete aging enhances consensus formation, shifting the critical point to higher values compared to the partial aging case. However, when the aging probability decays asymptotically to zero for large $τ$, a steady state is not always attained for complete aging.
Existing aging theories describe what changes with age but do not prescribe how to intervene. We propose a control-theoretic framework that is not merely descriptive but prescriptive: it specifies which intervention, at which dose and sequence, under which safety constraints, will restore a measured biological state to a functional region. Aging is defined as progressive loss of safe controllability; biological age is the minimum safe control cost of functional restoration. Drugs are modeled as vector fields on biological state space whose non-commutativity, quantified by Lie brackets, predicts that intervention order determines outcome. The core differentiation from prior theories is operational: the framework outputs ranked targets, optimal sequences, safety-constrained protocols, and falsifiable predictions directly usable in drug discovery, rather than mechanistic ontologies or correlative biomarkers. We present a five-dimensional ODE model with analytic Lie-bracket derivation, a modality-aware control layer, three translational case studies, an implementation architecture with power analysis, and empirical scoring of aging interventions across five biological epochs. Twenty fa
Automatically generated software, especially code produced by Large Language Models (LLMs), is increasingly adopted to accelerate development and reduce manual effort. However, little is known about the long-term reliability of such systems under sustained execution. In this paper, we experimentally investigate the phenomenon of software aging in applications generated by LLM-based tools. Using the Bolt platform and standardized prompts from Baxbench, we generated four service-oriented applications and subjected them to 50-hour load tests. Resource usage, response time, and throughput were continuously monitored to detect degradation patterns. The results reveal significant evidence of software aging, including progressive memory growth, increased response time, and performance instability across all applications. Statistical analyzes confirm these trends and highlight variability in the severity of aging according to the type of application. Our findings show the need to consider aging in automatically generated software and provide a foundation for future studies on mitigation strategies and long-term reliability evaluation.
Many drugs have been withdrawn from the market worldwide, at a cost of billions of dollars, because of patient fatalities due to them unexpectedly disturbing heart rhythm. Even drugs for ailments as mild as hay fever have been withdrawn due to an unacceptable increase in risk of these heart rhythm disturbances. Consequently, the whole pharmaceutical industry expends a huge effort in checking all new drugs for any unwanted side effects on the heart. The predominant root cause has been identified as drug molecules blocking ionic current flows in the heart. Block of individual types of ionic currents can now be measured experimentally at an early stage of drug development, and this is the standard screening approach for a number of ion currents in many large pharmaceutical companies. However, clinical risk is a complex function of the degree of block of many different types of cardiac ion currents, and this is difficult to understand by looking at results of these screens independently. By using ordinary differential equation models for the electrical activity of heart cells (electrophysiology models) we can integrate information from different types of currents, to predict the effect
A long term operation of Multi-Strip Multi-Gap Resistive Plate Chambers (MSMGRPC) with gas mixtures based on C2H2F4 and SF6 leads to aging effects, observed as depositions on the surface of the resistive electrodes. Moreover, enhanced depositions and higher noise rates were evidenced around the nylon spacers used for defining the gas gaps between the resistive electrodes. The aging effects are reflected in an increase of the dark current and dark counting rate, with negative impact on the long term performance of the chamber and data volume in a free running readout mode operation. MSMGRPC prototypes designed with a direct gas flow through the gas gaps and minimization of the number of spacers in the active area were developed as mitigation solution. Prototypes with this new design and different granularities were assembled using fishing line as spacers and investigated for aging effects. Although a significant reduction in the dark current and dark counting rate was evidenced, dark counting rate localized around the fishing line spacers remains. In this paper, a new generation of direct flow chambers based on discrete spacers is presented. The results of their aging investigations
While General Fractional Calculus has successfully expanded the scope of memory operators beyond power-laws, standard formulations remain predominantly restricted to the half-line via Riemann-Liouville or Caputo definitions. This constraint artificially truncates the system's history, limiting the thermodynamic consistency required for modeling processes on unbounded domains. To overcome these barriers, we construct the \textbf{Weighted Weyl-Sonine Framework}, a generalized formalism that extends non-local theory to the entire real line without history truncation. Unlike recent algebraic approaches based on conjugation for finite intervals, we develop a rigorous harmonic analysis framework. Our central contribution is the \textbf{Generalized Spectral Mapping Theorem}, which establishes the Weighted Fourier Transform as a unitary diagonalization map for these operators. This result allows us to rigorously classify and solve distinct physical regimes under a single algebraic structure. We explicitly derive exact solutions for \textit{diffusive relaxation} (governed by Complete Bernstein Functions), \textit{inertial wave propagation} (exhibiting oscillatory dynamics), and \textit{reta
This chapter demonstrates how computational social science (CSS) tools are extending and expanding research on aging. The depth and context from traditionally qualitative methods such as participant observation, in-depth interviews, and historical documents are increasingly employed alongside scalable data management, computational text analysis, and open-science practices. Machine learning (ML) and natural language processing (NLP), provide resources to aggregate and systematically index large volumes of qualitative data, identify patterns, and maintain clear links to in-depth accounts. Drawing on case studies of projects that examine later life--including examples with original data from the DISCERN study (a team-based ethnography of life with dementia) and secondary analyses of the American Voices Project (nationally representative interview)--the chapter highlights both uses and challenges of bringing CSS tools into more meaningful dialogue with qualitative aging research. The chapter argues such work has potential for (1) streamlining and augmenting existing workflows, (2) scaling up samples and projects, and (3) generating multi-method approaches to address important question
The role of additives such as FEC in extending the calendar life of silicon anodes beyond the cycling benefits is still not fully understood. Herein, the calendar life of high-loading Si (80 wt%) using baseline 1.2 M LiPF6 in EC-EMC electrolyte versus adding 10 wt% FEC is investigated over months. Over 8 days of aging, FEC leads to a 13-fold reduction in irreversible capacity loss in Si-LiFePO4 full cells. Cells without FEC are projected to fall below 80% of their initial capacity within approx. 22 days versus approx. 279 days with FEC. Symmetric Si-Si cells from harvested electrodes show greater increase in interphase resistance without FEC, whereby an increase of 10.81 Ohms is measured for 0 wt% FEC vs. only 3.37 Ohms for 10 wt% FEC over 2 months. Power law modeling of this long-term interphase resistance finds mixed transport-reaction growth behavior in FEC-free cells, suggesting significant dissolution, whereas cells with 10 wt% FEC added display a diffusion-controlled impedance growth behavior, suggesting a robust surface passivation film. Post-mortem FTIR and XPS confirm polycarbonate enrichment of the SEI, which was discovered to predominantly emerge from FEC self-polymeriza
Recent studies have demonstrated that network approaches are highly appropriate tools to understand the extreme complexity of the aging process. The generality of the network concept helps to define and study the aging of technological, social networks and ecosystems, which may give novel concepts to cure age-related diseases. The current review focuses on the role of protein-protein interaction networks (interactomes) in aging. Hubs and inter-modular elements of both interactomes and signaling networks are key regulators of the aging process. Aging induces an increase in the permeability of several cellular compartments, such as the cell nucleus, introducing gross changes in the representation of network structures. The large overlap between aging genes and genes of age-related major diseases makes drugs which aid healthy aging promising candidates for the prevention and treatment of age-related diseases, such as cancer, atherosclerosis, diabetes and neurodegenerative disorders. We also discuss a number of possible research options to further explore the potential of the network concept in this important field, and show that multi-target drugs (representing "magic-buckshots" inste
Extrusion-based 3D printing has become one of the most common additive manufacturing methods and is widely used in engineering. This contribution presents the results of flexural creep experiments on 3D printed PLA specimens, focusing on changes in creep behavior due to physical aging. It is shown experimentally that the creep curves obtained on aged specimens are shifted to each other on the logarithmic time scale in a way that the theory of physical aging can explain. The reason for the physical aging of 3D printed thermoplastics is assumed to be the special heat treatment that the polymer undergoes during extrusion. Additionally, results of a long-term flexural creep experiment are shown, demonstrating that non-negligible creep over long periods can be observed even at temperatures well below the glass transition temperature. Such creep effects should be considered for designing components made of 3D printed thermoplastics.
Background: Psychedelic drugs facilitate profound changes in consciousness and have potential to provide insights into the nature of human mental processes and their relation to brain physiology. Yet published scientific literature reflects a very limited understanding of the effects of these drugs, especially for newer synthetic compounds. The number of clinical trials and range of drugs formally studied is dwarfed by the number of written descriptions of the many drugs taken by people. Analysis of these descriptions using machine-learning techniques can provide a framework for learning about these drug use experiences. Methods: We collected 1000 reports of 10 drugs from the drug information website Erowid.org and formed a term-document frequency matrix. Using variable selection and a random-forest classifier, we identified a subset of words that differentiated between drugs. Results: A random forest using a subset of 110 predictor variables classified with accuracy comparable to a random forest using the full set of 3934 predictors. Our estimated accuracy was 51.1%, which compares favorably to the 10% expected from chance. Reports of MDMA had the highest accuracy at 86.9%; those
In the absence of sufficient medication for COVID patients due to the increased demand, disused drugs have been employed or the doses of those available were modified by hospital pharmacists. Some evidences for the use of alternative drugs can be found in the existing scientific literature that could assist in such decisions. However, exploiting large corpus of documents in an efficient manner is not easy, since drugs may not appear explicitly related in the texts and could be mentioned under different brand names. Drugs4Covid combines word embedding techniques and semantic web technologies to enable a drug-oriented exploration of large medical literature. Drugs and diseases are identified according to the ATC classification and MeSH categories respectively. More than 60K articles and 2M paragraphs have been processed from the CORD-19 corpus with information of COVID-19, SARS, and other related coronaviruses. An open catalogue of drugs has been created and results are publicly available through a drug browser, a keyword-guided text explorer, and a knowledge graph.
Large-size hybrid and pixelized GEM-Micromegas gaseous detectors (40x40 cm$^2$ active area) were developed and installed in 2014 and 2015 for the COMPASS2 physics program which started at the same time. That program involved in particular two full years of Drell-Yan studies using a high-intensity pion beam on a thick polarized target. Although the detectors were placed behind a thick absorber, they were exposed to an important flux of low energy neutrons and photons. The detectors were designed to drastically reduce the discharge rate, a major issue for non-resistive Micromegas in high hadron flux, by a factor of more than 100 compared to the former ones. A hybrid solution was chosen where a pre-amplifying GEM foil is placed 2 mm above the micromesh electrode. A pixelized readout was also added in the center of the detector, where the beam is going through, in order to track particles scattered at very low angles. The combination of the hybrid structure and the pixelized central readout allowed the detector to be operated in an environment with particle flux above 10 MHz/cm$^2$ with very good detection efficiencies and spatial resolution. The performance has remained stable since 2
Based on previous work done in this field, we build a dynamical system that describes changes in drug addiction in an isolated population when two addictive substances are available simultaneously. We then use our model to investigate whether the system captures the process of users switching drug habits. One of the motivations for this project is to mathematically check the conjecture that being addicted to a less-addictive substance will effectively lead individuals to become dependent on more addictive and potentially more dangerous drugs. We introduce additional assumptions, under which our model is reduced to a competitive Lotka-Volterra system. This dynamical system has three or four fixed points, stability of which then gives an implication about the outcomes of the competition between addictive substances and, therefore, the fate of individuals in the population. From the analysis of the reduced model, we determine that there actually exist parameter regimes that capture the following dynamics: depending on the initial distribution of the drug preference; either the use of both drugs will die out, the usage of one of the drugs will become prevalent, or addictions to both dr
Drug repurposing provides an opportunity to redeploy drugs, which ideally are already approved for use in humans, for the treatment of other diseases. For example, the repurposing of dexamethasone and baricitinib has played a crucial role in saving patient lives during the ongoing SARS-CoV-2 pandemic. There remains a need to expand therapeutic approaches to prevent life-threatening complications in patients with COVID-19. Using an in silico approach based on structural similarity to drugs already in clinical trials for COVID-19, potential drugs were predicted for repurposing. For a subset of identified drugs with different targets to their corresponding COVID-19 clinical trial drug, a mechanism of action analysis was applied to establish whether they might have a role in inhibiting the replication of SARS-CoV-2. Of sixty drugs predicted in this study, two with the potential to inhibit SARS-CoV-2 replication were identified using mechanism of action analysis. Triamcinolone is a corticosteroid that is structurally similar to dexamethasone; gallopamil is a calcium channel blocker that is structurally similar to verapamil. In silico approaches indicate possible mechanisms of action for
Adverse drug-drug interactions~(DDIs) can compromise the effectiveness of concurrent drug administration, posing a significant challenge in healthcare. As the development of new drugs continues, the potential for unknown adverse effects resulting from DDIs becomes a growing concern. Traditional computational methods for DDI prediction may fail to capture interactions for new drugs due to the lack of knowledge. In this paper, we introduce a new problem setup as zero-shot DDI prediction that deals with the case of new drugs. Leveraging textual information from online databases like DrugBank and PubChem, we propose an innovative approach TextDDI with a language model-based DDI predictor and a reinforcement learning~(RL)-based information selector, enabling the selection of concise and pertinent text for accurate DDI prediction on new drugs. Empirical results show the benefits of the proposed approach on several settings including zero-shot and few-shot DDI prediction, and the selected texts are semantically relevant. Our code and data are available at \url{https://github.com/zhufq00/DDIs-Prediction}.
Cardiovascular diseases remain the leading global cause of mortality. Age is an important covariate whose effect is most easily investigated in a healthy cohort to properly distinguish the former from disease-related changes. Traditionally, most of such insights have been drawn from the analysis of electrocardiogram (ECG) feature changes in individuals as they age. However, these features, while informative, may potentially obscure underlying data relationships. In this paper we present the following contributions: (1) We employ a deep-learning model and a tree-based model to analyze ECG data from a robust dataset of healthy individuals across varying ages in both raw signals and ECG feature format. (2) We use explainable AI methods to identify the most discriminative ECG features across age groups.(3) Our analysis with tree-based classifiers reveals age-related declines in inferred breathing rates and identifies notably high SDANN values as indicative of elderly individuals, distinguishing them from younger adults. (4) Furthermore, the deep-learning model underscores the pivotal role of the P-wave in age predictions across all age groups, suggesting potential changes in the distri
Coronavirus disease 2019 (COVID-19) has impacted almost every part of human life worldwide, posing a massive threat to human health. There is no specific drug for COVID-19, highlighting the urgent need for the development of effective therapeutics. To identify potentially repurposable drugs, we employed a systematic approach to mine candidates from U.S. FDA-approved drugs and preclinical small-molecule compounds by integrating the gene expression perturbation data for chemicals from the Library of Integrated Network-Based Cellular Signatures project with a publicly available single-cell RNA sequencing dataset from mild and severe COVID-19 patients. We identified 281 FDA-approved drugs that have the potential to be effective against SARS-CoV-2 infection, 16 of which are currently undergoing clinical trials to evaluate their efficacy against COVID-19. We experimentally tested the inhibitory effects of tyrphostin-AG-1478 and brefeldin-a on the replication of the single-stranded ribonucleic acid (ssRNA) virus influenza A virus. In conclusion, we have identified a list of repurposable anti-SARS-CoV-2 drugs using a systems biology approach.